Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.

Breccia, Massimo; Martelli, Maurizio; Cannella, Laura; Russo, Eleonora; Finolezzi, Erica; Stefanizzi, Caterina; Levi, Anna; Frustaci, Annamaria; Alimena, Giuliana

Breccia, Massimo; Martelli, Maurizio; Cannella, Laura; Russo, Eleonora; Finolezzi, Erica; Stefanizzi, Caterina; Levi, Anna; Frustaci, Annamaria; Alimena, Giuliana.

Affiliation

Breccia M; Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy. breccia@bce.uniromal.it

Leuk Res ; 32(2): 353-5, 2008 Feb.

Article in En | MEDLINE | ID: mdl-17825907

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Lymphoma, Non-Hodgkin/drug therapy; Neoplasms, Second Primary/drug therapy; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Murine-Derived; Benzamides; Breast Neoplasms/pathology; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology; Lymphoma, Non-Hodgkin/pathology; Middle Aged; Neoplasms, Second Primary/pathology; Piperazines/administration & dosage; Pyrimidines/administration & dosage; Rituximab

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Breast Neoplasms / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Leuk Res Year: 2008 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links